Back to companies

Stevanato Group S.p.A.

STVNITNYSEPharmaceuticals & Healthcare

Stevanato Group S.p.A.

Revenue
€1.2bn
YoY +7.4%
Operating income
€198.8mn
FY2025
Employees
—
Founded
—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API